NewVale Capital
Boulder, Coloradonewvalecapital.com
Overview
NewVale Capital is a growth equity investment firm founded in 2022 that focuses on supporting the services architecture of the life science industry. The firm invests in proven, revenue-generating services, software, and technology businesses across the pharmaceutical value chain, including discovery, clinical, manufacturing, and commercialization. It aims to invest in companies that help accelerate timelines, reduce costs, and improve quality in bringing new medicines to patients.
Portfolio Companies
4
Website
newvalecapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Noxilizer | Sep 2025 | Growth Equity | Lead |
| Argonaut Manufacturing Services | Mar 2024 | Series A | Lead |
| Aizon | Feb 2024 | Series C | Lead |
| Beaconcure | Jun 2023 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
